Common Stock, Shares Authorized of RELMADA THERAPEUTICS, INC. from Q3 2012 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
RELMADA THERAPEUTICS, INC. quarterly Common Stock, Shares Authorized history and change rate from Q3 2012 to Q3 2025.
  • RELMADA THERAPEUTICS, INC. Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 150M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 150M 0 0% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 150M 0 0% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 150M 0 0% 31 Mar 2025 10-Q 12 May 2025
Q4 2024 150M 0 0% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 150M 0 0% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 150M 0 0% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 150M 0 0% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 150M 0 0% 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 150M 0 0% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 150M 0 0% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 150M +100M +200% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 150M 0 0% 31 Dec 2022 10-K 19 Mar 2024
Q3 2022 150M +100M +200% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 150M +100M +200% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 50M 0 0% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 150M +100M +200% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 50M 0 0% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 50M 0 0% 30 Jun 2021 10-Q 10 Aug 2021
Q1 2021 50M 0 0% 31 Mar 2021 10-Q 12 May 2021
Q4 2020 50M 0 0% 31 Dec 2020 10-K 25 Mar 2022
Q3 2020 50M 0 0% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 50M 0 0% 30 Jun 2020 10-Q 12 Aug 2020
Q1 2020 50M -150M -75% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 50M -50M -50% 31 Dec 2019 10-K 24 Mar 2021
Q3 2019 50M -50M -50% 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 50M 0 0% 30 Jun 2019 10-K 24 Mar 2021
Q1 2019 200M +100M +100% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 100M 0 0% 31 Dec 2018 10-Q 13 Feb 2019
Q3 2018 100M 0 0% 30 Sep 2018 10-Q 13 Nov 2018
Q2 2018 50M -50M -50% 30 Jun 2018 10-KT 26 Mar 2020
Q1 2018 100M 0 0% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 100M 0 0% 31 Dec 2017 10-Q 12 Feb 2018
Q3 2017 100M 0 0% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 100M 0 0% 30 Jun 2017 10-K 28 Sep 2018
Q1 2017 100M 0 0% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 100M 0 0% 31 Dec 2016 10-Q 10 Feb 2017
Q3 2016 100M 0 0% 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 100M 0 0% 30 Jun 2016 10-K 28 Sep 2017
Q1 2016 100M -400M -80% 31 Mar 2016 10-Q 09 May 2016
Q4 2015 100M -400M -80% 31 Dec 2015 10-Q 05 Feb 2016
Q3 2015 100M -400M -80% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 100M 0 0% 30 Jun 2015 10-K 09 Sep 2016
Q1 2015 500M -500M -50% 31 Mar 2015 10-Q 15 May 2015
Q4 2014 500M 0 0% 31 Dec 2014 10-Q 13 Feb 2015
Q3 2014 500M +410M +456% 30 Sep 2014 10-Q 07 Nov 2014
Q2 2014 100M +10M +11.1% 30 Jun 2014 10-K 11 Sep 2015
Q1 2014 1B +910M +1011% 31 Mar 2014 8-K 27 May 2014
Q4 2013 500M -500M -50% 31 Dec 2013 10-KT 09 Sep 2014
Q3 2013 90M 0 0% 31 Aug 2013 10-Q 15 Apr 2014
Q2 2013 90M 31 May 2013 10-Q 12 Jul 2013
Q1 2013 90M 28 Feb 2013 10-Q 03 May 2013
Q4 2012 1B 31 Dec 2012 8-K 27 May 2014
Q3 2012 90M 31 Aug 2012 10-K 16 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.